Polikistik Over Sendromu - PCOS - www.jinekolojivegebelik.com
•
7 likes•2,616 views
PCOS is a common hormonal disorder characterized by oligomenorrhea and hyperandrogenism. It can cause long term health risks like diabetes, cardiovascular disease, and endometrial cancer. Management involves lifestyle changes like weight loss through diet and exercise to improve symptoms. Medications may be used to treat irregular periods, hirsutism, and help with ovulation induction and fertility. Screening for metabolic complications is recommended due to increased risk.
Report
Share
Report
Share
![Introduction ,[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
update on PCOS
The document discusses polycystic ovary syndrome (PCOS), including its prevalence, diagnosis, risk assessment, and treatment. It is the most common reproductive disorder in women, affecting 8-18% depending on the criteria used. Diagnosis involves assessing irregular menstrual cycles, clinical or biochemical signs of hyperandrogenism, and ovarian morphology on ultrasound. Women with PCOS have increased risks of cardiovascular disease, diabetes, obstructive sleep apnea, and endometrial cancer, so risk factors should be regularly monitored. Lifestyle changes including healthy diet, exercise, and weight loss are recommended as first-line treatment, especially for overweight or obese women.
Infertility and PCOS
This document discusses infertility and polycystic ovary syndrome (PCOS). It defines PCOS and outlines its diagnosis criteria. PCOS is diagnosed based on somatic or lab indicators of hyperandrogenism, oligo-anovulation, and polycystic ovarian morphology, while excluding other disorders. Treatment options for PCOS include weight loss, exercise, clomiphene, aromatase inhibitors, metformin, and gonadotropins. Long-term management may involve birth control pills, metformin therapy, and lifestyle changes to reduce risks of weight gain, hyperandrogenism, and cardiac or metabolic diseases.
PCOS IMPACT ON FERTILITY
This document discusses polycystic ovarian disorder (PCOD) and its impact on infertility. It begins by defining PCOD as a chronic hyperandrogenic state caused by cysts forming on the ovaries which prevent ovulation. It then discusses the characteristics, epidemiology, risk factors, pathophysiology, diagnosis, consequences such as infertility and increased health risks, and treatment options including lifestyle changes, medication, and surgery. The conclusion emphasizes that while PCOD cannot be cured, the symptoms and infertility can be treated, and maintaining a healthy lifestyle may decrease the risk of developing PCOD.
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assement
This document discusses recommendations for assessing polycystic ovary syndrome (PCOS). It covers diagnostic criteria including irregular menstrual cycles, hyperandrogenism, polycystic ovarian morphology on ultrasound, and anti-Müllerian hormone levels. It also discusses assessing cardiovascular, metabolic, and reproductive health risks associated with PCOS, including insulin resistance, impaired glucose tolerance, diabetes, and obesity. Ethnic variations in PCOS presentation and long-term health risks are also addressed.
OVARIAN RESERVE
This document discusses ovarian reserve, which refers to a woman's reproductive potential and is a function of the number and quality of her remaining oocytes. It declines with age due to a reduction in both quantity and quality of oocytes. Several tests can assess ovarian reserve, including antral follicle count (AFC), anti-Müllerian hormone (AMH) levels, and follicle-stimulating hormone (FSH) levels. AFC and AMH are currently considered the best tests as they have less variability than FSH. These tests can help predict response to fertility treatments and live birth outcomes. While they provide useful information, age is still the strongest predictor of ovarian reserve and reproductive potential.
Presentation on Fertility Challenges in Polycystic Ovary Syndrome (PCOS)
This document provides information about Dr. Laxmi Shrikhande's credentials and experience in gynecology and fertility. It then summarizes guidelines for assessing and managing polycystic ovary syndrome (PCOS) and infertility. Key recommendations include using letrozole as first-line pharmacological treatment for infertility in PCOS patients, and considering gonadotropins as second-line if letrozole fails. The risks of ovarian hyperstimulation syndrome are also discussed for PCOS patients undergoing fertility treatments like IVF.
Pcos
This document discusses polycystic ovarian syndrome (PCOS) and its impact on fertility. It notes that PCOS is the most common cause of infertility in women. The document covers the etiology, signs and symptoms, diagnostic criteria and tests, and treatment options for PCOS. It emphasizes that PCOS is associated with insulin resistance and an increased risk of conditions like diabetes and heart disease. Lifestyle changes including diet and exercise are recommended as first-line treatment, especially for overweight patients. Medications like metformin can also help address insulin resistance and related issues.
Endometriosis associated infertility: ESHRE2022
The document is a lecture on the treatment of endometriosis-associated infertility according to 2022 ESHRE guidelines. It discusses various treatment options including medical treatment with hormonal therapies, surgery, assisted reproductive technologies (ART), and fertility preservation. Key recommendations include that ovarian suppression should not be used to improve fertility. Surgery and ART may be considered depending on the stage of endometriosis and patient factors. Extensive counseling is recommended when discussing fertility preservation options.
Recommended
update on PCOS
The document discusses polycystic ovary syndrome (PCOS), including its prevalence, diagnosis, risk assessment, and treatment. It is the most common reproductive disorder in women, affecting 8-18% depending on the criteria used. Diagnosis involves assessing irregular menstrual cycles, clinical or biochemical signs of hyperandrogenism, and ovarian morphology on ultrasound. Women with PCOS have increased risks of cardiovascular disease, diabetes, obstructive sleep apnea, and endometrial cancer, so risk factors should be regularly monitored. Lifestyle changes including healthy diet, exercise, and weight loss are recommended as first-line treatment, especially for overweight or obese women.
Infertility and PCOS
This document discusses infertility and polycystic ovary syndrome (PCOS). It defines PCOS and outlines its diagnosis criteria. PCOS is diagnosed based on somatic or lab indicators of hyperandrogenism, oligo-anovulation, and polycystic ovarian morphology, while excluding other disorders. Treatment options for PCOS include weight loss, exercise, clomiphene, aromatase inhibitors, metformin, and gonadotropins. Long-term management may involve birth control pills, metformin therapy, and lifestyle changes to reduce risks of weight gain, hyperandrogenism, and cardiac or metabolic diseases.
PCOS IMPACT ON FERTILITY
This document discusses polycystic ovarian disorder (PCOD) and its impact on infertility. It begins by defining PCOD as a chronic hyperandrogenic state caused by cysts forming on the ovaries which prevent ovulation. It then discusses the characteristics, epidemiology, risk factors, pathophysiology, diagnosis, consequences such as infertility and increased health risks, and treatment options including lifestyle changes, medication, and surgery. The conclusion emphasizes that while PCOD cannot be cured, the symptoms and infertility can be treated, and maintaining a healthy lifestyle may decrease the risk of developing PCOD.
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assement
This document discusses recommendations for assessing polycystic ovary syndrome (PCOS). It covers diagnostic criteria including irregular menstrual cycles, hyperandrogenism, polycystic ovarian morphology on ultrasound, and anti-Müllerian hormone levels. It also discusses assessing cardiovascular, metabolic, and reproductive health risks associated with PCOS, including insulin resistance, impaired glucose tolerance, diabetes, and obesity. Ethnic variations in PCOS presentation and long-term health risks are also addressed.
OVARIAN RESERVE
This document discusses ovarian reserve, which refers to a woman's reproductive potential and is a function of the number and quality of her remaining oocytes. It declines with age due to a reduction in both quantity and quality of oocytes. Several tests can assess ovarian reserve, including antral follicle count (AFC), anti-Müllerian hormone (AMH) levels, and follicle-stimulating hormone (FSH) levels. AFC and AMH are currently considered the best tests as they have less variability than FSH. These tests can help predict response to fertility treatments and live birth outcomes. While they provide useful information, age is still the strongest predictor of ovarian reserve and reproductive potential.
Presentation on Fertility Challenges in Polycystic Ovary Syndrome (PCOS)
This document provides information about Dr. Laxmi Shrikhande's credentials and experience in gynecology and fertility. It then summarizes guidelines for assessing and managing polycystic ovary syndrome (PCOS) and infertility. Key recommendations include using letrozole as first-line pharmacological treatment for infertility in PCOS patients, and considering gonadotropins as second-line if letrozole fails. The risks of ovarian hyperstimulation syndrome are also discussed for PCOS patients undergoing fertility treatments like IVF.
Pcos
This document discusses polycystic ovarian syndrome (PCOS) and its impact on fertility. It notes that PCOS is the most common cause of infertility in women. The document covers the etiology, signs and symptoms, diagnostic criteria and tests, and treatment options for PCOS. It emphasizes that PCOS is associated with insulin resistance and an increased risk of conditions like diabetes and heart disease. Lifestyle changes including diet and exercise are recommended as first-line treatment, especially for overweight patients. Medications like metformin can also help address insulin resistance and related issues.
Endometriosis associated infertility: ESHRE2022
The document is a lecture on the treatment of endometriosis-associated infertility according to 2022 ESHRE guidelines. It discusses various treatment options including medical treatment with hormonal therapies, surgery, assisted reproductive technologies (ART), and fertility preservation. Key recommendations include that ovarian suppression should not be used to improve fertility. Surgery and ART may be considered depending on the stage of endometriosis and patient factors. Extensive counseling is recommended when discussing fertility preservation options.
Endometriosis and Infertility
Invited Lecture delivered by Dr Sujoy Dasgupta in a CME, sponsored by Serum Institute of India Pvt Ltd in the Convocation Ceremony of Interns at Sagor Dutta Medical College
Pcos in adolescents
This document provides an overview of Polycystic Ovary Syndrome (PCOS), including its definition, causes, symptoms, diagnostic criteria and treatment approaches. Some key points:
- PCOS is a common endocrine disorder in women characterized by irregular periods, excess androgen and polycystic ovaries. Its exact cause is unknown but involves genetic and hormonal factors.
- Diagnosis is based on the Rotterdam criteria which requires two of three features: irregular periods, clinical or biochemical signs of excess androgen, or polycystic ovaries seen on ultrasound.
- Treatment focuses on lifestyle changes like weight loss to reduce insulin resistance, and medications like metformin and anti-androgens to regulate periods and
PREMATURE OVARIAN INSUFFICIENCY ESHRE Guidelines, 2015
This document provides guidelines for the diagnosis and management of premature ovarian insufficiency (POI). It defines POI as depletion of follicular activity before age 40, characterized by menstrual disturbances, raised gonadotropins, and low estrogen. The prevalence is approximately 1% in the general population. Causes include genetic factors, autoimmune disorders, infections, chemotherapy and radiation. Management focuses on hormone replacement therapy (HRT) to reduce long-term health risks, fertility options, and treatment of symptoms like reduced bone mineral density and increased cardiovascular risk.
PANEL DISCUSSION MANAGEMENT OF PCOS WOMB to TOMB
PANEL DISCUSSION
MANAGEMENT OF PCOS - WOMB to TOMB
MODERATOR : Sharda Jain
PANELISTS : Dr.Chitra setia
Dr Puneet Arora
Dr. Ila Gupta
Dr. Rupam Arora
Dr. Archana Sharma
Dr. Sangeeta Gupta
Dermatologists
Dr. V.K. Upadhyay
Dr. S. Kandhari
Evidence based PCOs
This document discusses evidence-based approaches to managing polycystic ovarian syndrome (PCOS). It recommends screening women with PCOS for glucose intolerance and dyslipidemia. Lifestyle modifications including weight loss are a first approach but many patients struggle with weight loss. Medications like clomiphene citrate are effective for inducing pregnancy. Adding metformin to clomiphene is not recommended based on evidence from randomized controlled trials. Management of PCOS aims to treat infertility, hirsutism, and long-term risks of insulin resistance.
Low amh what next
The document provides information about the qualifications and achievements of Dr. Laxmi Shrikhande. It lists her positions including Chairperson Elect of ICOG, National Corresponding Editor of a journal, founder and president of various organizations. It also lists some of the awards she has received for her work in women's health and related fields. The document then provides her name and credentials as Medical Director of Shrikhande Fertility Clinic in Nagpur, Maharashtra.
Current Management of Anovulatory Infertility
Presentation given at the weekly departmental seminar of the LAUTECH teaching hospital, Ogbomoso. Nigeria
LEAN VS OBESE PCOS Myths & Facts Dr Sharda Jain & Dr Jyoti Agarwal
1) Both lean and obese phenotypes of PCOS have similar symptoms like menstrual irregularity and hirsutism, though weight gain is only seen in obese PCOS.
2) While obesity increases the risk of PCOS, it is not the sole cause as genetics and environmental factors also contribute.
3) Both phenotypes can experience insulin resistance, so lifestyle changes and insulin sensitizers may benefit both groups.
Obesity in male infertility by dr. sharda jain, Dr. Jyoti Agarwal, Dr. Jyoti ...
This document discusses how obesity reduces fertility in men. It finds that obese men are about twice as likely to be infertile as men of normal weight. Obesity is associated with decreased sperm count and quality, including lower sperm motility and morphology. The mechanisms by which obesity harms male fertility include increased oxidative stress, hormonal imbalances and hypogonadism, and the accumulation of compounds that interfere with fertility. Losing even 5-10% of body weight through diet and exercise can help improve semen quality and fertility outcomes. Assisted reproduction techniques like ICSI may also help obese men who struggle with infertility.
AMH OVARIAN RESERVE MARKER Dr Jyoti Bhasker ,Dr. Sharda Jain Dr. Jyoti Ag...
This document summarizes markers of ovarian reserve and methods for testing ovarian reserve. It discusses how anti-Mullerian hormone (AMH) levels provide a better indicator of ovarian reserve than other markers, as AMH levels change least between cycles and are unaffected by other factors. AMH testing can help personalize infertility treatment by predicting response and tailoring stimulation protocols based on a patient's AMH level and ovarian reserve.
Recurrent pregnancy loss panel discussion
This document discusses recurrent pregnancy loss and provides information on definitions, incidence, causes, investigations, and guidelines. Some key points:
- Recurrent pregnancy loss is defined as 3 or more clinically recognized pregnancy losses before 20 weeks. The incidence is about 1 in 300 pregnancies.
- Common causes include genetic factors in the parents or embryo, anatomic abnormalities, endocrine/immune/infectious factors, and inherited thrombophilias.
- Investigations should include parental karyotyping after 2 losses, and karyotyping of pregnancy tissues is recommended by RCOG guidelines to provide counseling and predict outcomes of future pregnancies.
- Biomarkers and ultrasound can provide information on predicting outcomes,
Presentation on Diagnosis of Polycystic Ovary Syndrome (PCOS)
This document provides information about Dr. Laxmi Shrikhande, including her credentials and positions held in various medical societies. It then discusses polycystic ovary syndrome (PCOS) and new international guidelines for diagnosing and managing PCOS published in 2018. Key points from the guidelines regarding diagnosing PCOS in adolescents and lifestyle and medical interventions for managing PCOS are summarized.
Induction of ovulation
Induction of ovulation
oral injectable clomiphesne citrate letrozole GNT GnRH
unilatral or bilateral ovarian drilling
Polycystic ovarian syndrome
Polycystic ovarian syndrome (PCOS) is a condition
of unexplained hyperandrogenic chronic anovulation
that most likely represents a heterogenous disorder.
About 10% of women in the reproductive age group
suffer from this disorder.
Treatment guid line 2018 PCOD Treatment by Dr Sharda Jain Dr Jyoti Agarwal
This document discusses the treatment of polycystic ovarian syndrome (PCOS) based on what has been learned over the past 50 years and 2018 international guidelines. It covers:
- Lifestyle changes like weight loss and exercise remain the primary treatment approach as there is no cure for PCOS.
- Pharmacological treatments include combined oral contraceptives, metformin, and anti-androgens, which may help with irregular periods, excess hair growth, acne, and fertility issues.
- The 2018 guidelines endorse previous diagnostic criteria and recommend treatments based on the latest evidence, focusing on improving reproductive, metabolic, and psychological health through lifestyle and medical interventions.
AMH Screening in Infertility
Dr Sujoy Dasgupta was invited to deliver a lecture at East Zone Yuva FOGSI Conference held at Guwahati, Assam
Endometriosis and Infertility
This document discusses endometriosis and its relationship to infertility. It covers several key points:
1. Endometriosis has three main types - peritoneal, ovarian, and rectovaginal - which are different entities.
2. Endometriosis can result in infertility through mechanical effects, endocrine abnormalities, changes to peritoneal fluid, immune system issues, and defects in oocytes.
3. Diagnosis is confirmed through laparoscopy, and mild or minimal endometriosis associated with infertility can be treated through laparoscopic destruction, expectant management, or GnRH agonists. Surgery aims to decrease inflammation and toxicity.
4. For endometriomas,
Integrated approach to infertility work up
This document outlines an integrated approach to infertility workup. It discusses evaluating the male partner, ovarian function, tubal function, and the uterus. For the male partner, a history, examination, and semen analysis are recommended. Ovarian function is assessed through menstrual history, ultrasound, and hormone levels. Tubal function can be evaluated with HSG, laparoscopy, or hysteroscopy. The uterus is examined with imaging like HSG, ultrasound, or hysteroscopy and potentially endometrial biopsy. A complete workup considers factors from both the male and female partners.
Tackling Obesity in Infertility
Dr Sujoy Dasgupta was invited to deliver a lecture in the CME organized by Meyer Organic, held at Kolkata in June 2019
PCOS
Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age, affecting 5-10% of women. It is characterized by hyperandrogenism, chronic anovulation, and polycystic ovaries. PCOS increases the risk of metabolic syndrome, diabetes, cardiovascular disease, and endometrial cancer. Treatment involves lifestyle modifications like weight loss and exercise. Pharmacological treatments include combined oral contraceptives to regulate menstrual cycles and metformin to reduce insulin resistance. PCOS management may involve specialists like gynecologists, endocrinologists, and dietitians.
PCOS
Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women, affecting around 1 million females in Germany. It is characterized by menstrual irregularities, excess androgen levels, and polycystic ovaries. PCOS causes infertility due to chronic anovulation from hyperandrogenism and insulin resistance. Women with PCOS have an increased risk of obesity, diabetes, cardiovascular disease, and other metabolic complications. The cause of PCOS involves genetic and environmental factors, and its features vary in severity and combination of symptoms between individuals.
Pcos
PCOS is an intergenerational problem having its origin in adolesence with lot of metabolic dysfunction.
More Related Content
What's hot
Endometriosis and Infertility
Invited Lecture delivered by Dr Sujoy Dasgupta in a CME, sponsored by Serum Institute of India Pvt Ltd in the Convocation Ceremony of Interns at Sagor Dutta Medical College
Pcos in adolescents
This document provides an overview of Polycystic Ovary Syndrome (PCOS), including its definition, causes, symptoms, diagnostic criteria and treatment approaches. Some key points:
- PCOS is a common endocrine disorder in women characterized by irregular periods, excess androgen and polycystic ovaries. Its exact cause is unknown but involves genetic and hormonal factors.
- Diagnosis is based on the Rotterdam criteria which requires two of three features: irregular periods, clinical or biochemical signs of excess androgen, or polycystic ovaries seen on ultrasound.
- Treatment focuses on lifestyle changes like weight loss to reduce insulin resistance, and medications like metformin and anti-androgens to regulate periods and
PREMATURE OVARIAN INSUFFICIENCY ESHRE Guidelines, 2015
This document provides guidelines for the diagnosis and management of premature ovarian insufficiency (POI). It defines POI as depletion of follicular activity before age 40, characterized by menstrual disturbances, raised gonadotropins, and low estrogen. The prevalence is approximately 1% in the general population. Causes include genetic factors, autoimmune disorders, infections, chemotherapy and radiation. Management focuses on hormone replacement therapy (HRT) to reduce long-term health risks, fertility options, and treatment of symptoms like reduced bone mineral density and increased cardiovascular risk.
PANEL DISCUSSION MANAGEMENT OF PCOS WOMB to TOMB
PANEL DISCUSSION
MANAGEMENT OF PCOS - WOMB to TOMB
MODERATOR : Sharda Jain
PANELISTS : Dr.Chitra setia
Dr Puneet Arora
Dr. Ila Gupta
Dr. Rupam Arora
Dr. Archana Sharma
Dr. Sangeeta Gupta
Dermatologists
Dr. V.K. Upadhyay
Dr. S. Kandhari
Evidence based PCOs
This document discusses evidence-based approaches to managing polycystic ovarian syndrome (PCOS). It recommends screening women with PCOS for glucose intolerance and dyslipidemia. Lifestyle modifications including weight loss are a first approach but many patients struggle with weight loss. Medications like clomiphene citrate are effective for inducing pregnancy. Adding metformin to clomiphene is not recommended based on evidence from randomized controlled trials. Management of PCOS aims to treat infertility, hirsutism, and long-term risks of insulin resistance.
Low amh what next
The document provides information about the qualifications and achievements of Dr. Laxmi Shrikhande. It lists her positions including Chairperson Elect of ICOG, National Corresponding Editor of a journal, founder and president of various organizations. It also lists some of the awards she has received for her work in women's health and related fields. The document then provides her name and credentials as Medical Director of Shrikhande Fertility Clinic in Nagpur, Maharashtra.
Current Management of Anovulatory Infertility
Presentation given at the weekly departmental seminar of the LAUTECH teaching hospital, Ogbomoso. Nigeria
LEAN VS OBESE PCOS Myths & Facts Dr Sharda Jain & Dr Jyoti Agarwal
1) Both lean and obese phenotypes of PCOS have similar symptoms like menstrual irregularity and hirsutism, though weight gain is only seen in obese PCOS.
2) While obesity increases the risk of PCOS, it is not the sole cause as genetics and environmental factors also contribute.
3) Both phenotypes can experience insulin resistance, so lifestyle changes and insulin sensitizers may benefit both groups.
Obesity in male infertility by dr. sharda jain, Dr. Jyoti Agarwal, Dr. Jyoti ...
This document discusses how obesity reduces fertility in men. It finds that obese men are about twice as likely to be infertile as men of normal weight. Obesity is associated with decreased sperm count and quality, including lower sperm motility and morphology. The mechanisms by which obesity harms male fertility include increased oxidative stress, hormonal imbalances and hypogonadism, and the accumulation of compounds that interfere with fertility. Losing even 5-10% of body weight through diet and exercise can help improve semen quality and fertility outcomes. Assisted reproduction techniques like ICSI may also help obese men who struggle with infertility.
AMH OVARIAN RESERVE MARKER Dr Jyoti Bhasker ,Dr. Sharda Jain Dr. Jyoti Ag...
This document summarizes markers of ovarian reserve and methods for testing ovarian reserve. It discusses how anti-Mullerian hormone (AMH) levels provide a better indicator of ovarian reserve than other markers, as AMH levels change least between cycles and are unaffected by other factors. AMH testing can help personalize infertility treatment by predicting response and tailoring stimulation protocols based on a patient's AMH level and ovarian reserve.
Recurrent pregnancy loss panel discussion
This document discusses recurrent pregnancy loss and provides information on definitions, incidence, causes, investigations, and guidelines. Some key points:
- Recurrent pregnancy loss is defined as 3 or more clinically recognized pregnancy losses before 20 weeks. The incidence is about 1 in 300 pregnancies.
- Common causes include genetic factors in the parents or embryo, anatomic abnormalities, endocrine/immune/infectious factors, and inherited thrombophilias.
- Investigations should include parental karyotyping after 2 losses, and karyotyping of pregnancy tissues is recommended by RCOG guidelines to provide counseling and predict outcomes of future pregnancies.
- Biomarkers and ultrasound can provide information on predicting outcomes,
Presentation on Diagnosis of Polycystic Ovary Syndrome (PCOS)
This document provides information about Dr. Laxmi Shrikhande, including her credentials and positions held in various medical societies. It then discusses polycystic ovary syndrome (PCOS) and new international guidelines for diagnosing and managing PCOS published in 2018. Key points from the guidelines regarding diagnosing PCOS in adolescents and lifestyle and medical interventions for managing PCOS are summarized.
Induction of ovulation
Induction of ovulation
oral injectable clomiphesne citrate letrozole GNT GnRH
unilatral or bilateral ovarian drilling
Polycystic ovarian syndrome
Polycystic ovarian syndrome (PCOS) is a condition
of unexplained hyperandrogenic chronic anovulation
that most likely represents a heterogenous disorder.
About 10% of women in the reproductive age group
suffer from this disorder.
Treatment guid line 2018 PCOD Treatment by Dr Sharda Jain Dr Jyoti Agarwal
This document discusses the treatment of polycystic ovarian syndrome (PCOS) based on what has been learned over the past 50 years and 2018 international guidelines. It covers:
- Lifestyle changes like weight loss and exercise remain the primary treatment approach as there is no cure for PCOS.
- Pharmacological treatments include combined oral contraceptives, metformin, and anti-androgens, which may help with irregular periods, excess hair growth, acne, and fertility issues.
- The 2018 guidelines endorse previous diagnostic criteria and recommend treatments based on the latest evidence, focusing on improving reproductive, metabolic, and psychological health through lifestyle and medical interventions.
AMH Screening in Infertility
Dr Sujoy Dasgupta was invited to deliver a lecture at East Zone Yuva FOGSI Conference held at Guwahati, Assam
Endometriosis and Infertility
This document discusses endometriosis and its relationship to infertility. It covers several key points:
1. Endometriosis has three main types - peritoneal, ovarian, and rectovaginal - which are different entities.
2. Endometriosis can result in infertility through mechanical effects, endocrine abnormalities, changes to peritoneal fluid, immune system issues, and defects in oocytes.
3. Diagnosis is confirmed through laparoscopy, and mild or minimal endometriosis associated with infertility can be treated through laparoscopic destruction, expectant management, or GnRH agonists. Surgery aims to decrease inflammation and toxicity.
4. For endometriomas,
Integrated approach to infertility work up
This document outlines an integrated approach to infertility workup. It discusses evaluating the male partner, ovarian function, tubal function, and the uterus. For the male partner, a history, examination, and semen analysis are recommended. Ovarian function is assessed through menstrual history, ultrasound, and hormone levels. Tubal function can be evaluated with HSG, laparoscopy, or hysteroscopy. The uterus is examined with imaging like HSG, ultrasound, or hysteroscopy and potentially endometrial biopsy. A complete workup considers factors from both the male and female partners.
Tackling Obesity in Infertility
Dr Sujoy Dasgupta was invited to deliver a lecture in the CME organized by Meyer Organic, held at Kolkata in June 2019
PCOS
Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age, affecting 5-10% of women. It is characterized by hyperandrogenism, chronic anovulation, and polycystic ovaries. PCOS increases the risk of metabolic syndrome, diabetes, cardiovascular disease, and endometrial cancer. Treatment involves lifestyle modifications like weight loss and exercise. Pharmacological treatments include combined oral contraceptives to regulate menstrual cycles and metformin to reduce insulin resistance. PCOS management may involve specialists like gynecologists, endocrinologists, and dietitians.
What's hot (20)
PREMATURE OVARIAN INSUFFICIENCY ESHRE Guidelines, 2015
PREMATURE OVARIAN INSUFFICIENCY ESHRE Guidelines, 2015
LEAN VS OBESE PCOS Myths & Facts Dr Sharda Jain & Dr Jyoti Agarwal
LEAN VS OBESE PCOS Myths & Facts Dr Sharda Jain & Dr Jyoti Agarwal
Obesity in male infertility by dr. sharda jain, Dr. Jyoti Agarwal, Dr. Jyoti ...
Obesity in male infertility by dr. sharda jain, Dr. Jyoti Agarwal, Dr. Jyoti ...
AMH OVARIAN RESERVE MARKER Dr Jyoti Bhasker ,Dr. Sharda Jain Dr. Jyoti Ag...
AMH OVARIAN RESERVE MARKER Dr Jyoti Bhasker ,Dr. Sharda Jain Dr. Jyoti Ag...
Presentation on Diagnosis of Polycystic Ovary Syndrome (PCOS)
Presentation on Diagnosis of Polycystic Ovary Syndrome (PCOS)
Treatment guid line 2018 PCOD Treatment by Dr Sharda Jain Dr Jyoti Agarwal
Treatment guid line 2018 PCOD Treatment by Dr Sharda Jain Dr Jyoti Agarwal
Viewers also liked
PCOS
Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women, affecting around 1 million females in Germany. It is characterized by menstrual irregularities, excess androgen levels, and polycystic ovaries. PCOS causes infertility due to chronic anovulation from hyperandrogenism and insulin resistance. Women with PCOS have an increased risk of obesity, diabetes, cardiovascular disease, and other metabolic complications. The cause of PCOS involves genetic and environmental factors, and its features vary in severity and combination of symptoms between individuals.
Pcos
PCOS is an intergenerational problem having its origin in adolesence with lot of metabolic dysfunction.
Pcos
This document discusses polycystic ovary syndrome (PCOS) in a 22-year-old woman presenting with irregular periods, weight gain, and signs of hyperandrogenism. PCOS is characterized by ovulatory dysfunction, hyperandrogenism, and polycystic ovaries. It increases the risk of metabolic syndrome, diabetes, and cardiovascular disease. Treatment involves lifestyle changes, oral contraceptives, clomiphene or letrozole for ovulation induction, and antiandrogens depending on the patient's symptoms and fertility goals. Screening for metabolic and endocrine abnormalities is also recommended.
Laparoscopic ovarian drilling
Laparoscopic ovarian drilling (LOD) is an alternative treatment for women with polycystic ovarian syndrome (PCOS) who are resistant to clomiphene citrate ovulation induction. LOD involves using electrocautery or laser energy to create multiple small openings in the ovarian capsule. This surgical trauma restores hypothalamic-pituitary-ovarian function and results in ovulation rates of 50-90% and pregnancy rates of 64-76%. LOD avoids risks of multiple pregnancy and ovarian hyperstimulation syndrome associated with gonadotropin treatments, and results in sustained fertility benefits for several years with minimal risks. Guidelines recommend LOD as a first-line treatment alternative to gonadotrop
Pcod(polycystic ovary disease) problem, pcos most common factor for woman i...
PCOD is a common problem among youth. Dr Sweta Gupta(https://www.elawoman.com/gurgaon/doctor/dr-sweta-gupta) of Medicover Fertility(https://www.elawoman.com/delhi/clinic/medicover-fertility-clinic-panchsheel-park) it is suggested to loose weight in PCOD whereas Dr. Sagarika Aggarwal(https://www.elawoman.com/delhi/doctor/dr-sagarika-aggarwal) of Indira IVF (https://www.elawoman.com/delhi/clinic/indira-ivf-south-patel-nagar)says eat fruits and vegetables to avoid PCOD.
LIFESTYLE MANAGEMENT OF PCOS BY DR SHASHWAT JANI
This document discusses lifestyle management approaches for PCOS, including diet, exercise, and weight loss. It notes that lifestyle management targeting weight loss and prevention of weight gain should include both reduced calorie intake and exercise. Exercise of at least 150 minutes per week is recommended for women with PCOS to reduce metabolic risks. Even a 5-10% loss of body weight through lifestyle changes can help restore ovulation and improve PCOS symptoms.
Ivf in pcos
This document discusses IVF treatment for polycystic ovary syndrome (PCOS). It begins with an overview of PCOS prevalence, definitions, and diagnostic criteria. IVF is indicated for PCOS patients who fail to conceive after ovulation induction or have other fertility factors. Patient preparation, gonadotropin protocols and monitoring, triggering ovulation, embryo transfer, and luteal phase support are discussed. Outcomes are better with GnRH antagonist protocols for PCOS patients due to lower gonadotropin doses and risk of ovarian hyperstimulation syndrome (OHSS). Primary and secondary prevention of OHSS includes metformin use, coasting, cryopreservation of embryos, and GnRH agonist triggering of ovulation.
Polycystic ovarian syndrome & amenorrhea
Polycystic Ovarian Syndrome (PCOS) is one of the most common endocrine disorders among females of reproductive age. It is characterized by oligoovulation or anovulation, hyperandrogenism, and polycystic ovaries. The cause is unknown but there is strong evidence of a genetic component. Symptoms include irregular periods, hirsutism, acne, obesity and risk of diabetes. Treatment focuses on reducing androgen levels, protecting the endometrium, weight loss, and inducing ovulation when pregnancy is desired. Long term monitoring is also needed due to increased risk of diabetes, cardiovascular disease and obstetric complications.
revision on cases of reproductive endocrinology
Undergraduate course lectures in Gynecology prepared by DR Manal Behery ,FACULTY OF MEDICINE ,Zagazig UNIVERSITY,EGYPT
Infertility treatment related to PCOS
The document discusses infertility treatment related to polycystic ovary syndrome (PCOS). Lifestyle modifications like weight loss and increased physical activity are recommended as first-line treatment for obesity in PCOS patients. Clomiphene citrate is the first choice for ovulation induction, while gonadotropins and laparoscopic ovarian drilling are recommended as second-line treatments if clomiphene citrate fails. In vitro fertilization is an effective third-line treatment option for infertility in women with PCOS, as it can achieve pregnancy while minimizing the risk of multiple pregnancies.
Ppt pcos
Polycystic ovary syndrome (PCOS) is characterized by menstrual irregularity, hyperandrogenism, and polycystic ovaries. It affects 5-10% of women of reproductive age. Key features include ovarian dysfunction, hyperandrogenemia, polycystic ovaries on ultrasound, gonadotropin abnormalities, insulin resistance, dyslipidemia, and obesity. Treatment focuses on lifestyle modifications like diet and exercise as well as medications to address symptoms and underlying causes. Women with PCOS have an increased risk of diabetes and cardiovascular disease.
RCT of the effects of Metformin Vs COCs in adolescent PCOS women through a 2...
This randomized controlled trial compared the effects of metformin and combined oral contraceptives (COCs) in adolescent women with polycystic ovary syndrome (PCOS) over 24 months. 119 adolescent girls were randomly assigned to receive metformin, COCs, or no treatment (control group). Both metformin and COCs significantly improved cycle regularity and hirsutism compared to the control group. However, metformin was associated with significant improvement in insulin sensitivity, while COCs deteriorated insulin sensitivity. The study concludes that metformin and COCs have comparable effects on symptoms, but metformin may have metabolic advantages in adolescent PCOS patients.
Pcos jodhpur
This document discusses polycystic ovary syndrome (PCOS) and the role of anti-müllerian hormone (AMH) in diagnosing and managing PCOS. It provides a history of PCOS and discusses its prevalence. It describes the underlying ovarian defect and criteria for diagnosis. It proposes that AMH levels could replace polycystic ovarian morphology in diagnostic criteria as AMH correlates with severity and hyperandrogenism. Higher AMH levels are seen in PCOS and reflect increased small follicles. AMH may help tailor individual treatment protocols and predict response to fertility treatments. The document concludes that AMH has potential as a prognostic marker and diagnostic tool that could improve PCOS diagnosis and management.
Pcos and infertility
This document discusses a case of a 33-year-old nulliparous and obese woman presenting with infertility after 5 years of marriage. It defines infertility, discusses its etiologies including tubal disease, endovascular factors, and unexplained infertility. It also discusses lifestyle advice for improving fertility in males and females. The document then discusses polycystic ovarian syndrome (PCOS), describing its pathophysiology, diagnostic criteria using Rotterdam criteria, and clinical and biochemical signs of hyperandrogenism. It also discusses scenarios involving male factor infertility and use of ovarian stimulation and IVF.
Pcos
PCOS (Polycystic Ovary Syndrome) is a combined metabolic and hormonal disorder found in women. Incidences of PCOS appear to be rising and it is now being diagnosed more often.It is seen in as many as 25 to 30% of young women.Unfortunately, due to unfavorable lifestyle changes the number of incidences of PCOS and PCOD (Polycystic Ovarian Disorder) are on rise.
This Presentation Includes
1. What is PCOS?
2. Symptoms of PCOS
3. PCOS risk factors
4. Life Style Factors and PCOS
5. Testing PCOS
6. PCOS linked Infertility
7. Managing PCOS
8. Life Style Changes to manage PCOS
Management of PCOS in Unani System of Medicine by Dr. Shaikh Nikhat
Management of PCOS in Unani System of Medicine by Dr. Shaikh NikhatHealth Education Library for People
For more Info visit www.healthlibrary.com "Management of PCOS in Unani System of Medicine" by Dr. Shaikh Nikhat held on 11th June 2016.
Management of PCOS in Unani System of Medicine - Unani system have the holistic approach to treat the condition like PCOD / PCOS.Evidence -based Management of PCOS
Seminar Evidence Based Obstetric & Gynecology POGI Cabang Surabaya
17 Juli 2016 - Pullman Hotel Surabaya
Polikistik Over Sendromu - PCOS - www.jinekolojivegebelik.com
The document discusses Polycystic Ovary Syndrome (PCOS), the most common endocrinopathy among women of reproductive age. PCOS is diagnosed based on two of three criteria: irregular periods, signs of high androgen levels, and enlarged ovaries with cysts. Women with PCOS have increased risks of infertility, metabolic and cardiovascular issues. Key aspects of PCOS include irregular periods due to hormonal imbalances, high androgen levels, insulin resistance, and enlarged ovaries. Treatment focuses on lifestyle changes, medication to manage symptoms and address insulin resistance, and fertility support.
PANEL DISCUSSION MANAGEMENT OF PCOS WOMB to TOMB . PANELISTS : Dr.Chitra...
This document summarizes a panel discussion on the management of polycystic ovarian syndrome (PCOS) from womb to tomb. The panel was moderated by Dr. Sharda Jain and included several specialists. PCOS has a continuum from early pre-pubertal years through menopause. Common symptoms in adolescents include menstrual irregularity, hyperandrogenism, acne, and hirsutism. Menstrual irregularity needs treatment to reduce endometrial cancer risk. Diagnosis involves evaluating hormones, blood sugar, and polycystic ovaries on ultrasound. Treatment focuses on managing clinical symptoms specific to each patient.
7 classical symptoms of pcos by dr.shailesh phalle
we had described 7 classical symptoms of pcos in simple language for patients. kindly visit your physician for detail diagnosis.
regards ayusanjivani ayurveada
Viewers also liked (20)
Pcod(polycystic ovary disease) problem, pcos most common factor for woman i...
Pcod(polycystic ovary disease) problem, pcos most common factor for woman i...
RCT of the effects of Metformin Vs COCs in adolescent PCOS women through a 2...
RCT of the effects of Metformin Vs COCs in adolescent PCOS women through a 2...
Management of PCOS in Unani System of Medicine by Dr. Shaikh Nikhat
Management of PCOS in Unani System of Medicine by Dr. Shaikh Nikhat
Polikistik Over Sendromu - PCOS - www.jinekolojivegebelik.com
Polikistik Over Sendromu - PCOS - www.jinekolojivegebelik.com
PANEL DISCUSSION MANAGEMENT OF PCOS WOMB to TOMB . PANELISTS : Dr.Chitra...
PANEL DISCUSSION MANAGEMENT OF PCOS WOMB to TOMB . PANELISTS : Dr.Chitra...
7 classical symptoms of pcos by dr.shailesh phalle
7 classical symptoms of pcos by dr.shailesh phalle
Similar to Polikistik Over Sendromu - PCOS - www.jinekolojivegebelik.com
POLYCYSTIC OVARIAN SYNDROME.pdf
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder among women of reproductive age with a prevalence of around 22.5% in India. It is characterized by oligomenorrhea, hirsutism, weight gain, and infertility. Long term risks include type 2 diabetes and cardiovascular disease. The exact cause is unknown but genetic, metabolic and environmental factors are involved. Diagnosis requires two of three criteria of hyperandrogenism, ovulatory dysfunction, and polycystic ovaries. Management involves lifestyle modification, oral contraceptives, insulin sensitizers like metformin, and ovulation induction drugs.
PCOS & Pregnancy - 임옥룡 박사
This document summarizes polycystic ovarian syndrome (PCOS), including its prevalence, diagnostic criteria, pathophysiology, manifestations, laboratory tests, differential diagnoses, risks, and treatment options. Key points include: PCOS is the most common female endocrinopathy, affecting 5-10% of women; it is diagnosed using the Rotterdam criteria including oligo/anovulation and hyperandrogenism; insulin resistance and compensatory hyperinsulinemia play a major role in its pathogenesis; manifestations involve cutaneous, reproductive, and metabolic systems; and treatment focuses on lifestyle changes like weight loss, oral contraceptives, metformin, and therapies targeting specific symptoms.
Polikistik Over Sendromu - PCOS - www.jinekolojivegebelik.com
This document provides an overview of polycystic ovarian syndrome (PCOS), including its pathogenesis, diagnosis, and management. PCOS is characterized by hyperandrogenism, oligoovulation or anovulation, and polycystic ovaries. It affects 4-12% of women and is associated with insulin resistance and related metabolic complications. Diagnosis requires two of the three above criteria in the absence of other disorders. Management involves lifestyle changes, medications to regulate cycles and reduce hair growth, and long-term strategies to address insulin resistance and related risks like cardiovascular disease.
Management of INFERTILITY in PCOD Difficulties & Solutions Made Easy , Dr....
This document discusses the management of infertility in patients with polycystic ovarian syndrome (PCOS). It begins by outlining the types of patients seen, including those with anovulatory infertility, obesity, and menstrual irregularities. The challenges of PCOS treatment in women aged 20-40 are then presented, including concerns about infertility, pregnancy loss, and risks during pregnancy like preeclampsia and gestational diabetes. Treatment options for infertility in PCOS patients are then discussed, including clomiphene citrate, gonadotropins, laparoscopic ovarian drilling, and metformin. Protocols for ovarian stimulation with clomiphene citrate and gonadotropins are also presented.
PCOS
Polycystic Ovarian Syndrome (PCOS) is a hormonal disorder common among women of reproductive age, affecting around 5-10% of women. It is characterized by enlarged ovaries with multiple small cysts, irregular or absent menstrual periods, excess androgen and male pattern hair growth. The exact cause is unknown but involves genetic and environmental factors such as obesity and insulin resistance. The long term effects of PCOS include an increased risk of type 2 diabetes, cardiovascular disease, endometrial cancer and infertility. Treatment focuses on managing symptoms such as irregular periods, excess hair growth and weight loss through lifestyle changes and medication.
POLYCYSTIC OVARIAN SYNDROME
PCOS is a common metabolic and reproductive disorder among women of reproductive age. It involves uncontrolled ovarian steroidogenesis, aberrant insulin signaling, excessive oxidative stress, and genetic/environmental factors. PCOS is diagnosed based on hyperandrogenism and ovarian dysfunction or polycystic ovaries. AMH levels correlate with antral follicle count and can help assess ovarian reserve. Metformin helps treat PCOS by reducing insulin resistance and its effects on the ovaries, and may help fertility outcomes, though optimal dosing is unclear and side effects can cause discontinuation. Lifestyle changes focusing on diet and exercise remain important first-line approaches.
Lect 2-polycystic ovarian syndrome
Polycystic Ovarian Syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age, characterized by increased androgen production and irregular menstrual cycles. PCOS is associated with infertility, hirsutism, insulin resistance, obesity, and increased risk of diabetes and heart disease. Diagnosis is based on hyperandrogenism, chronic anovulation or oligomenorrhea, and exclusion of other disorders. Treatment focuses on regulating menses, managing insulin resistance and weight loss, and addressing long-term health risks.
Management of Adolescent PCOD Made Easy ,Dr. Sharda Jain Dr. Jyoti Agarwal...
This document discusses the diagnosis and management of polycystic ovarian syndrome (PCOS) in adolescents. It provides information on the prevalence of PCOS in adolescents in India being near 18-20% according to some studies. The diagnostic criteria for PCOS have evolved over time from the NIH criteria in 1990 to the Rotterdam criteria in 2003 to current standards. Key diagnostic tests and evaluations discussed include assessing symptoms, signs of hyperandrogenism, menstrual history, ultrasound of the ovaries, and lab tests like testosterone, LH, and glucose levels. Management of PCOS focuses on treatment of symptoms and reducing risks of issues like obesity, insulin resistance, infertility and other long term health consequences.
PCOS.. international guidelines ..changes everyone wants to know
this presentation deals with the major changes highlighted in the recent guidelines so it can help people to understand it in simple lanuage.
Polycystic ovarian Syndrome
This document provides an overview of polycystic ovary syndrome (PCOS), including its definition, epidemiology, pathophysiology, diagnostic criteria, presentations, investigations, and management. Some key points:
- PCOS is defined as chronic hyperandrogenism and evidence of anovulation. It is a common endocrine disorder among young women.
- The exact cause is unclear but is thought to involve ovarian androgen excess and disturbed hormone regulation. Genetics also play a role.
- Presentations include irregular periods, excess hair growth, acne, obesity, and infertility. Diagnosis involves assessing hormones and ultrasound of ovaries.
- Management focuses on weight loss, medication to improve hormone balance and
Pco & hirsutism
This document discusses polycystic ovarian syndrome (PCOS) and hirsutism. PCOS is a syndrome characterized by ovarian dysfunction, hyperandrogenism, and polycystic ovaries. It has no clear cause but is often genetic. Clinical features include irregular periods, hirsutism, obesity, and infertility. Diagnosis requires two of three features: irregular periods, clinical hyperandrogenism, or polycystic ovaries seen on ultrasound. Long-term risks include diabetes and heart disease. Treatment involves lifestyle changes, birth control pills, metformin, and clomiphene to induce ovulation. Hirsutism is excessive male-pattern hair growth and can be caused by PCOS or other conditions.
Guidelines For Management Of Adolescent PCOS
The document provides guidelines for managing adolescent polycystic ovarian syndrome (PCOS), outlining a framework that includes identifying at-risk children, accurately diagnosing adolescent PCOS based on updated criteria from ESHRE 2018, and managing symptoms while preventing long-term consequences through lifestyle modifications and screening for issues like cardiovascular risk, diabetes, depression, and sleep apnea.
PCOS.pptx
1. Polycystic ovary syndrome (PCOS) is a complex clinical syndrome with unclear etiology and various risk factors including genetics, environment, and obesity.
2. PCOS is characterized by menstrual irregularities, hirsutism, acne, infertility and obesity. It can cause insulin resistance, endometrial cancer risk, and other metabolic complications.
3. Diagnosis of PCOS involves requiring two of three criteria - oligo/amenorrhea, clinical or biochemical signs of hyperandrogenism, and polycystic ovaries on ultrasound. Differential diagnoses must be excluded.
pcos presentation .pptx
This document provides an overview of polycystic ovarian syndrome (PCOS). It defines PCOS as a hormonal disorder causing enlarged ovaries with small cysts. It discusses the prevalence of PCOS, affecting 8-20% of women of childbearing age. The causes of PCOS include excess insulin, heredity, and low-grade inflammation. Symptoms include irregular periods, acne, excess hair growth and obesity. Long term risks include diabetes, heart disease and cancer. The document outlines diagnostic criteria and tests used to diagnose PCOS. Treatments discussed include lifestyle changes, medication and surgery.
Aj gynecomastia 15 aug 2011
This document defines gynecomastia and discusses its evaluation and treatment. It describes the differences between true gynecomastia involving breast glandular tissue and pseudogynecomastia involving only fat deposition. It reviews the hormonal causes and various etiologies including physiological causes in infancy, adolescence and older age as well as pathological causes like tumors, liver disease and drugs. Evaluation involves history, exam and potential labs or imaging depending on risk factors. Treatment options include watchful waiting, medications or surgery depending on factors like size and duration.
Diagnosis of PCOS MCMCTACONSESSION4.pptx
This document provides guidance on diagnosing and managing polycystic ovarian syndrome (PCOS) in adolescents. Key points include:
- Adult PCOS diagnostic criteria are not applicable to adolescents due to normal irregular periods and cystic ovaries during puberty.
- Recommended diagnostic approach involves assessing for unexplained hyperandrogenism and ovarian dysfunction after ruling out other conditions.
- Management involves lifestyle changes like weight loss, exercise and diet, as well as symptom-focused treatments like birth control pills, anti-androgens and insulin-sensitizing agents.
- The goals are to alleviate current symptoms, decrease future health risks of PCOS like infertility, metabolic syndrome and diabetes. Care must be taken to
Polikistik Over Sendromu ve İnfertilite /Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is a common endocrine disorder of uncertain cause that affects 5-15% of women. It is characterized by polycystic ovaries, excess androgen production, and menstrual irregularity. Women with PCOS have an increased risk of infertility, endometrial cancer, diabetes, cardiovascular disease, and obesity. Treatment involves weight management, lifestyle changes, and medications to target symptoms such as irregular periods, hirsutism, and infertility.
Polycystic ovary syndrome
This document discusses polycystic ovarian syndrome (PCOS). It affects 4-9% of women and is a leading cause of infertility. PCOS is characterized by ovarian dysfunction causing irregular periods and hyperandrogenism leading to hirsutism and acne. Insulin resistance plays a key role in many cases of PCOS through a complex interplay of hormones. Management involves lifestyle changes like weight loss, medication to regulate periods and reduce androgens, and fertility treatments.
Ueda 2016 2-pathophysiology ,classification & diagnosis of diabetes - kha...
This document outlines an agenda and presentation on the pathophysiology, screening, diagnosis and classification of diabetes given at a mini-course in Aswan, Egypt in February 2016. The presentation covers:
1. The normal physiology and definition of diabetes and its chronic hyperglycemia-related complications.
2. The clinical classes of diabetes including type 1, type 2, gestational diabetes and other specific types.
3. The pathophysiology, risk factors, screening and diagnosis of type 1, type 2 and gestational diabetes are discussed in further detail.
4. The goals of the course are to help participants in advance of an upcoming conference on diabetes.
PCOS presentation 11.ppt
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder affecting women of childbearing age. It is characterized by irregular or absent menstrual periods, high androgen levels, and cysts on the ovaries. Women with PCOS have an increased risk of infertility, diabetes, heart disease, and endometrial cancer. The cause of PCOS is unknown but involves insulin resistance and hyperandrogenism. Diagnosis is based on clinical signs and imaging of polycystic ovaries. Treatment focuses on managing symptoms, improving insulin sensitivity, and ovulation induction for infertility.
Similar to Polikistik Over Sendromu - PCOS - www.jinekolojivegebelik.com (20)
Polikistik Over Sendromu - PCOS - www.jinekolojivegebelik.com
Polikistik Over Sendromu - PCOS - www.jinekolojivegebelik.com
Management of INFERTILITY in PCOD Difficulties & Solutions Made Easy , Dr....
Management of INFERTILITY in PCOD Difficulties & Solutions Made Easy , Dr....
Management of Adolescent PCOD Made Easy ,Dr. Sharda Jain Dr. Jyoti Agarwal...
Management of Adolescent PCOD Made Easy ,Dr. Sharda Jain Dr. Jyoti Agarwal...
PCOS.. international guidelines ..changes everyone wants to know
PCOS.. international guidelines ..changes everyone wants to know
Polikistik Over Sendromu ve İnfertilite /Polycystic Ovary Syndrome
Polikistik Over Sendromu ve İnfertilite /Polycystic Ovary Syndrome
Ueda 2016 2-pathophysiology ,classification & diagnosis of diabetes - kha...
Ueda 2016 2-pathophysiology ,classification & diagnosis of diabetes - kha...
More from jinekolojivegebelik.com
Trombofililer ve Gebelik - www.jinekolojivegebelik.com
Trombofililer ve Gebelik - www.jinekolojivegebelik.com
Rh-Rh Kan uyuşmazlığı - www.jinekolojivegebelik.com
Rh-Rh Kan uyuşmazlığı - www.jinekolojivegebelik.com
Postpartum (Doğum Sonrası) Aile Planlaması - www.jinekolojivegebelik.com
Postpartum (Doğum Sonrası) Aile Planlaması - www.jinekolojivegebelik.com
Gebelik ve Trombofili - www.jinekolojivegebelik.com
Gebelik ve Trombofili - www.jinekolojivegebelik.com
Gebelikte Akciğer Hastalıkları - www.jinekolojivegebelik.com
Gebelikte Akciğer Hastalıkları - www.jinekolojivegebelik.com
Preeklampsi, Eklampsi - www.jinekolojivegebelik.com
Preeklampsi, Eklampsi - www.jinekolojivegebelik.com
Oral Kontraseptifler - www.jinekolojivegebelik.com
Oral Kontraseptifler - www.jinekolojivegebelik.com
Pelvic Organ Prolapse - POP- www.jinekolojivegebelik:com
Pelvic organ prolapse occurs when one or more pelvic organs, such as the bladder, uterus, or rectum, descend from their normal positions due to weakness or damage in the muscles and tissues that support these organs. The document discusses the anatomy of pelvic floor support, factors that can contribute to prolapse, and how different types of prolapse such as cystocele, rectocele, and enterocele are evaluated and treated. Conservative treatments focus on lifestyle changes while surgical repairs aim to reconstruct the weakened pelvic floor tissues and fascia.
Evaluation Management of Genital Prolapse - www.jinekolojivegebelik.com
This document discusses the evaluation and management of genital prolapse. It begins by describing normal uterine and vaginal support structures. It then discusses the pathophysiology of pelvic organ prolapse, including neuromuscular dysfunction and weakness of supporting ligaments. Evaluation involves history, physical exam including staging systems, and sometimes additional tests. Treatment options include conservative approaches like pessaries or intravaginal devices, as well as surgical options.
Complications of mesh and should we use it ? - www.jinekoklojivegebelik.com
The document discusses the use of mesh in pelvic organ prolapse (POP) surgery, comparing synthetic and biological meshes. It summarizes various studies that have found complication rates ranging from 0-39% for synthetic meshes and 0-64% for biological meshes. While mesh may be preferable for recurrent or complex cases, there is no strong evidence currently to support its routine use in POP surgery. Further research through RCTs and pooled audits is still needed.
Postpartum Complications - www.jinekolojivegebelik.com
The document discusses several potential postpartum complications including postpartum hemorrhage, infection, urinary incontinence, prolapse, and mental health issues. Postpartum hemorrhage is the leading cause of maternal mortality and can be life-threatening, with causes such as uterine atony, lacerations, and retained placenta. Other complications include infection, urinary incontinence, structural issues like prolapse, and mental health issues such as postpartum depression. Prevention, early assessment, and treatment are emphasized to manage complications.
Abdomen, Pelvis and Perineum Anatomy - www.jinekolojivegebelik.com
This document provides an overview of abdominal anatomy terminology and structures. It discusses the internal coverings of the abdomen including the peritoneum and mesenteries. It then covers the blood supply and innervation of the foregut, midgut, and hindgut. Finally, it discusses some common congenital abnormalities that can occur in embryonic development of the gastrointestinal tract.
Gebelik Kolestazı -Cholestasis of Pregnancy - www.jinekolojivegebelik.com
1. Intrahepatic cholestasis of pregnancy is characterized by pruritus and jaundice in the last trimester of pregnancy, and can recur in subsequent pregnancies.
2. Laboratory findings include elevated serum bile acids and liver enzymes. The condition can cause complications like preterm birth and fetal distress.
3. Treatment focuses on relieving pruritus through medications like cholestyramine, antihistamines, phenobarbital, and ursodeoxycholic acid. Delivery may be indicated if symptoms are severe or fetal well-being is compromised.
Polikistik Over Sendromu - PCOS - www.jinekolojivegebelik.com
PCOS was first described in 1935 and affects 5-10% of women of reproductive age, making it the most common endocrine disorder. It is characterized by hyperandrogenism, chronic anovulation, and polycystic ovaries. Patients often see multiple medical practitioners before receiving a correct diagnosis of PCOS due to its variable signs and symptoms. Women with PCOS are also at higher risk of developing diabetes, cardiovascular disease, and other metabolic complications. Lifestyle interventions including diet and exercise can help manage symptoms and reduce health risks associated with PCOS.
Amenore - Anovulasyon - www.jinekolojivegebelik.com
Case 1 involves a 17-year-old female with primary amenorrhea who has normal development and health history. Her physical exam and labs are normal except she is underweight. She likely has hypothalamic amenorrhea due to inadequate calorie and fat intake and should be evaluated for an eating disorder.
Case 2 is a 24-year-old woman with secondary amenorrhea and irregular periods. She is overweight with signs of PCOS like acne and hirsutism. Her labs show elevated testosterone and cystic ovaries on ultrasound consistent with a diagnosis of PCOS.
Case 3 is a 29-year-old with secondary amenorrhea and a history of spontaneous abortion and D&
Amenore - www.jinekolojivegebelik.com
1. The document discusses various causes of amenorrhea including hypothalamic, pituitary, ovarian, and outflow tract issues.
2. Evaluation involves assessing secondary sex characteristics, symptoms, family history, and targeted medical tests.
3. Treatment focuses on identifying and managing underlying disorders, hormone replacement, and addressing risks like osteoporosis or infertility.
More from jinekolojivegebelik.com (20)
Trombofililer ve Gebelik - www.jinekolojivegebelik.com
Trombofililer ve Gebelik - www.jinekolojivegebelik.com
Rh-Rh Kan uyuşmazlığı - www.jinekolojivegebelik.com
Rh-Rh Kan uyuşmazlığı - www.jinekolojivegebelik.com
Postpartum (Doğum Sonrası) Aile Planlaması - www.jinekolojivegebelik.com
Postpartum (Doğum Sonrası) Aile Planlaması - www.jinekolojivegebelik.com
Gebelik ve Trombofili - www.jinekolojivegebelik.com
Gebelik ve Trombofili - www.jinekolojivegebelik.com
Gebelikte Akciğer Hastalıkları - www.jinekolojivegebelik.com
Gebelikte Akciğer Hastalıkları - www.jinekolojivegebelik.com
Preeklampsi, Eklampsi - www.jinekolojivegebelik.com
Preeklampsi, Eklampsi - www.jinekolojivegebelik.com
Oral Kontraseptifler - www.jinekolojivegebelik.com
Oral Kontraseptifler - www.jinekolojivegebelik.com
Pelvic Organ Prolapse - POP- www.jinekolojivegebelik:com
Pelvic Organ Prolapse - POP- www.jinekolojivegebelik:com
Evaluation Management of Genital Prolapse - www.jinekolojivegebelik.com
Evaluation Management of Genital Prolapse - www.jinekolojivegebelik.com
Complications of mesh and should we use it ? - www.jinekoklojivegebelik.com
Complications of mesh and should we use it ? - www.jinekoklojivegebelik.com
Postpartum Complications - www.jinekolojivegebelik.com
Postpartum Complications - www.jinekolojivegebelik.com
Abdomen, Pelvis and Perineum Anatomy - www.jinekolojivegebelik.com
Abdomen, Pelvis and Perineum Anatomy - www.jinekolojivegebelik.com
Gebelik Kolestazı -Cholestasis of Pregnancy - www.jinekolojivegebelik.com
Gebelik Kolestazı -Cholestasis of Pregnancy - www.jinekolojivegebelik.com
Polikistik Over Sendromu - PCOS - www.jinekolojivegebelik.com
Polikistik Over Sendromu - PCOS - www.jinekolojivegebelik.com
Amenore - Anovulasyon - www.jinekolojivegebelik.com
Amenore - Anovulasyon - www.jinekolojivegebelik.com
Recently uploaded
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Top Travel Vaccinations in Manchester
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital in Powai, Mumbai, is a premier healthcare institution that has been serving the community with exceptional medical care since its establishment. As a part of the renowned Hiranandani Group, the hospital is committed to delivering world-class healthcare services across a wide range of specialties, including kidney transplantation. With its state-of-the-art facilities, advanced medical technology, and a team of highly skilled healthcare professionals, Hiranandani Hospital has earned a reputation as a trusted name in the healthcare industry. The hospital's patient-centric approach, coupled with its focus on innovation and excellence, ensures that patients receive the highest standard of care in a compassionate and supportive environment.
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Identifying Major Symptoms of Slip Disc.
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
share - Lions, tigers, AI and health misinformation, oh my!.pptx
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Journal Article Review on Rasamanikya
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
The Nervous and Chemical Regulation of Respiration
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Recently uploaded (20)
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Polikistik Over Sendromu - PCOS - www.jinekolojivegebelik.com
- 1. PCOS Dr. Mridula A Benjamin Dept of Obs and Gyn RIPAS Hospital, Brunei
- 15. Metabolic syndrome 3 of the following 1. Waist circumference >88cm 2. Triglycerides >150 mg/dl 3. HDL <50 mg/dl 4. Blood pressure > 130/85 5. Fasting Blood glucose 110-126 &/or 2-h glucose 140-199 mg/dl
- 18. Cholesterol Pregnenolone Progesterone 17 OH-Pregnenolone 17 OH-Progesterone DHEA Androstenandion 17-20 Lyase 17 hydroxylase Theca cell Estrone estradiol Granulosa cell FSH LH OVARIAN STEROIDOGENESIS T
- 19. Obesity Insulin Free testosterone SHBG IGF-1 5-alfa reductase activity is stimulated IGF*** insulin like growth factor
- 21. Wt. increase Insulin receptor disorder Insulin increase Free estradiol increase High LH Low FSH Free testosterone increase Androstenandione increase SHBG decrease atresia Theca (IGF-I) Endometrial cancer Testosterone increase Estrone increase hirsutism IGFBP-I **** decrease IGFBP*** insulin like growth factor binding protein
- 29. STEPWISE APPROACH FOR OVULATION INDUCTION IN PCOS (ACOG,2002 ) 1. Weight loss: If BMI >30 K/m 2 2. Clomiphene citrate 3. CC + corticosteroids if DHES > 2ug/ml 4. CC + Metformin 5. Low dose FSH injection 6. Low dose FSH injection + Metformin 7. Ovarian drilling 8. IVF
- 37. Thank you